Historical record - last NADAC publication: 1/15/2019

Product Information

LOTREL 10-20 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $11.2952 per EA under NDC 00078036405. Its NADAC has been published 321 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the amlodipine besylate and benazepril hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LOTREL 10-20 MG CAPSULE

amlodipine besylate and benazepril hydrochloride
$11.2952per EA
High Outlier

Strength

10; 20 mg/1; mg/1

NDC

00078036405

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

1/15/2019

Approval Type

New Drug (NDA)

FDA Application

NDA020364

On Market Since

3/3/1995

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Decreased Blood Pressure
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for LOTREL 10-20 MG CAPSULE has been published 321 times since Nov 28, 2013, and over the history we have for it it has risen 110.6%. The table below summarizes its recorded NADAC range and movement.

Current price$11.2952 per EA
All-time high$11.2952 (Jan 15, 2020)
All-time low$5.3646 (Nov 28, 2013)
Median price$9.3113
Average price$9.0785
Largest weekly change+14.9% (Jan 14, 2015)
Weeks tracked321
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+110.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the amlodipine besylate and benazepril hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of LOTREL 10-20 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LOTREL 10-20 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $11.2952 per EA (NDC 00078036405), effective Jan 15, 2020.

How has the price of LOTREL 10-20 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LOTREL 10-20 MG CAPSULE has risen 110.6%. It has been tracked across 321 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LOTREL 10-20 MG CAPSULE?

Since Nov 28, 2013, the NADAC for LOTREL 10-20 MG CAPSULE has ranged from a low of $5.3646 (Nov 28, 2013) to a high of $11.2952 (Jan 15, 2020), with a median of $9.3113 per EA.

Are there cheaper alternatives to LOTREL 10-20 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LOTREL 10-20 MG CAPSULE, so no direct lower-cost alternative is listed.

Who manufactures LOTREL 10-20 MG CAPSULE?

LOTREL 10-20 MG CAPSULE (NDC 00078036405) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.